During the past decade, Jung Min Koo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Jung Min Koo" are "Chest Wall Disorder" (1 trials) and "Pectus Excavatum" (1 trials). Many other conditions were trialed in "Jung Min Koo" in a lesser frequency.

Most popular intervention types in "Jung Min Koo" are "Dietary Supplement" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexmedetomidine" (1 trials) and "New Care No Nil Per Os" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jung Min Koo" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Jung Min Koo". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Jung Min Koo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jung Min Koo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".